Forus raises $150M at $3B valuation for drug access tool

Forus, a company using AI to accelerate access to specialty medicines, raised $150 million in a Series C round, valuing it at $3 billion.

Why it matters: It's the latest funding haul for a startup focused on back-office workflows, as competition grows among venture-backed companies.